Simplex Trading
LTRN icon

Simplex Trading’s Lantern Pharma LTRN Stock Holding History

Simplex Trading’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.19K Sell
2,171
-166
-7% -$400 ﹤0.01% 8535
2026
Q2 		$9.7K Buy
2,337
+2,230
+2,084% +$6.54K ﹤0.01% 7710
2026
Q1 		$146 Sell
107
-2,150
-95% -$6.01K ﹤0.01% 8855
2025
Q4 		$6.84K Buy
2,257
+831
+58% +$3.09K ﹤0.01% 7236
2025
Q3 		$6K Buy
+1,426
New +$5.95K ﹤0.01% 8203
2024
Q4 		– Sell
-3,104
Closed -$10.6K – 9151
2024
Q3 		$11K Sell
3,104
-96
-3% -$395 ﹤0.01% 7126
2024
Q2 		$14K Buy
3,200
+272
+9% +$1.64K ﹤0.01% 7190
2024
Q1 		$25K Buy
+2,928
New +$15.6K ﹤0.01% 6911
2022
Q4 		– Sell
-373
Closed -$1K – 9880
2022
Q3 		$1K Sell
373
-664
-64% -$3.57K ﹤0.01% 9568
2022
Q2 		$5K Buy
1,037
+228
+28% +$1.36K ﹤0.01% 8838
2022
Q1 		$5K Buy
+809
New +$5.4K ﹤0.01% 9424

Other funds holding LTRN

CM
CM Management Gulf Breeze, Florida $149M AUM 35.54% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
BIOS Capital Management
BIOS Capital Management Fort Worth, Texas $34.2M AUM 13.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Westside Investment Management
Westside Investment Management Santa Monica, California $785M AUM 29.89% 1-Year Est. Return
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
NewEdge Advisors
NewEdge Advisors New Orleans, Louisiana $34.5B AUM 23.55% 1-Year Est. Return

Simplex Trading's LTRN Position: Q3 2026 in Review

Simplex Trading reduced its Lantern Pharma (LTRN) stake by 7.1% in Q3 2026, selling an estimated $400 and leaving 2,171 shares worth $2.19K. The position accounts for ﹤0.01% of the portfolio, ranked #8535.

Simplex Trading first reported a position in LTRN in Q1 2022 and has held it in 11 quarters since. The position peaked at $25K in Q1 2024. 36 funds tracked by Wall St. Rank hold LTRN as of Q3 2026.

  • Simplex Trading held 2,171 shares of Lantern Pharma worth $2.19K as of Q3 2026.
  • Simplex Trading sold 166 Lantern Pharma shares in Q3 2026, an estimated $400.
  • Lantern Pharma made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #8535 holding.
  • Simplex Trading first reported a position in Lantern Pharma in Q1 2022 and has held it in 11 quarters since.
  • Simplex Trading's Lantern Pharma position peaked at $25K in Q1 2024.
  • 36 funds tracked by Wall St. Rank held Lantern Pharma as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.